Skip to content
Open access

Characterization of the circadian system in binge eating disorder and the effects of morning bright light and individually timed exogenous melatonin administration: A 4-week feasibility double-blind randomized controlled mechanistic clinical trial

Aug 2026 · Research Square · 0 citations · 97 references
Medicine

TL;DR

A later circadian phase correlated with greater BED severity, and dampened actigraphy rhythms, both support circadian disruption in BED.

Abstract

Introduction: Binge eating disorder (BED) exhibits features consistent with circadian system dysregulation. This two-phase study mechanistically examined BED chronobiology. We hypothesized that dim light melatonin onset (DLMO; circadian phase) is delayed in BED and associated with illness characteristics, and be modifiable via a chronobiotic intervention. Methods: Phase 1 (P1) was a 2-week observational study comparing adults with obesity with BED (n = 43) and without BED (controls, n = 41). Phase 2 (P2) was a 4-week double-blind, randomized, controlled pilot trial in BED (NCT04724668). Participants received morning bright light (BLT; 10,000 lx) plus individually timed exogenous melatonin (3 mg) administration (BLT+ITEMA, n = 13) or sham red light (50 lx) plus placebo (n = 10). Primary outcomes were baseline DLMO differences (P1) and DLMO change (P2). Secondary/exploratory measures included wrist actigraphy and clinical features. ANCOVA, correlation, and Bayesian methods were used for statistical analysis. Results: In P1, DLMO did not differ between groups, but later DLMO correlated with greater BED severity. BED participants showed lower 24-hour locomotor amplitude and MESOR (both, posterior probability [pp] = 1), poorer diet quality, higher night eating and leptin levels (all p < 0.05). In P2, DLMO change did not differ between groups. Compared to sham+placebo, BLT+ITEMA participants had smaller reductions in peak activity (pp = 0.97) and amplitude (pp = 0.87), plus increased dietary restraint and LcN-3 fatty acids (both p < 0.05). Later baseline DLMO correlated with greater phase advance and binge eating reduction (both p < 0.05). The intervention was well tolerated. Conclusions: A later circadian phase correlated with greater BED severity, and dampened actigraphy rhythms, both support circadian disruption in BED. The mechanistic intervention is feasible and warrants refinement.

Read PDF

Similar papers

Open access Aug 2026

Effect of a 12-Week Structured Yogic Intervention on Circadian Rhythm Imbalance in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial

There exists frequent coexistence of circadian rhythm disorders with polycystic ovary syndrome (PCOS), which worsens symptoms like hyperandrogenism, insulin resistance, and sleep disturbance, however, the use of non-pharmacological interventions that affect biological clock is poorly studied. In this randomized control...

Shyam Tank, Charu Mehandiratta · 0 citations
Open access Sep 2026

Weight loss maintenance one year after modified intermittent fasting in circadian-disrupted night shift workers: longer-term secondary outcomes from the SWIFt randomised clinical trial

It is shown that at 18 months, mean difference in weight and HOMA-IR does not appear to differ between groups, although the study may have insufficient power to detect small but clinically meaningful effects.

R. Davis, G. Leung, M. Rogers et al. · 0 citations
Open access Sep 2026

Responsiveness of ThymoDream® as a natural modulator of the circadian axis: a comparative RCT with melatonin supplementation employing melatonin profiling and actigraphy

Introduction Non-restorative sleep is frequently associated with disturbances in circadian regulation, impaired sleep quality, and reduced daytime functioning. Methods This randomized, double-blind, active-controlled, cross over study compared black cumin oil extract (TD; 200 mg) with synthetic melatonin (s-Mel; 5 mg/d...

C. S. Harshith, Thomas V. Jestin, Das S. Syam et al. · 0 citations
Open access Aug 2026

Effects of bedtime melatonin treatment on blood pressure and arterial stiffness: a three-month, randomized, placebo-controlled crossover study in individuals with type 2 diabetes mellitus.

In this randomized placebo-controlled trial of individuals with type 2 diabetes, 3 months of treatment with 10 mg melatonin administered one hour before bedtime did not significantly affect blood pressure or pulse wave velocity.

E. S. Lauritzen, Julie Støy, N. Møller et al. · 0 citations
Open access Aug 2026

Improvements in sleep, weight, and eating-disorder symptoms following off-label leptin treatment in an adolescent with chronic anorexia nervosa and insomnia: a case report

We report off-label administration of human recombinant leptin (metreleptin) over a 12-day period in a 17-year-old female adolescent with chronic anorexia nervosa (AN) and clinically significant insomnia. Two observation windows are distinguished throughout: a short-term window between day 1 (pre) and day 12 (post) of...

A. Dück, Hang Zhu, Judith Melinat et al. · 0 citations
Open access Aug 2026

Circadian rhythm amplification in diabetic retinopathy: a pilot study

Amplify-RHYTHM resulted in less insomnia symptoms, more regular sleep, reduced behavioral circadian fragmentation, and reduced systemic inflammation in type 2 diabetes with DR.

S. Reutrakul, J. McAnany, Jason C. Park et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.